Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2016 Feb;50(2):249-54.
doi: 10.1016/j.amepre.2015.11.011.

The Economics of Breast Cancer in Younger Women in the U.S.: The Present and Future

Donatus U Ekwueme  1 , Justin G Trogdon  2
Affiliations
Editorial

The Economics of Breast Cancer in Younger Women in the U.S.: The Present and Future

Donatus U Ekwueme et al. Am J Prev Med. 2016 Feb.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Illustration of the conceptual framework of the articles in this theme issue. Note: # means the number of articles in the theme issue. Health state utility (HSU) values are scaled to a single 0 (dead) to 1 (best health) cardinal index. HSU is a special health-related quality of life measure that represents global health-related well-being, is based on preference-based tradeoffs, and is used in economic evaluations to value improvements in morbidity and mortality from interventions (e.g., quality-adjusted life-years).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784–1792. http://dx.doi.org/10.1056/NEJMoa050518. - DOI - PubMed
    1. Elkin EB, Hudis CA. Parsing progress in breast cancer. J Clin Oncol. 2015;33(26):2837–2838. http://dx.doi.org/10.1200/JCO.2015.62.4890. - DOI - PubMed
    1. Park J-H, Andersen WF, Gail MH. Improvements in U.S. breast cancer survival and proportion explained by tumor size and estrogen-receptor status. J Clin Oncol. 2015;33(26):2870–2876. http://dx.doi.org/10.1200/JCO.2014.59.9191. - DOI - PMC - PubMed
    1. Figueroa-Magalhães MC, Jelovac D, Connolly RM, et al. Treatment of HER2-positive breast cancer. Breast. 2014;23(2):128–136. http://dx.doi.org/10.1016/j.breast.2013.11.011. - DOI - PMC - PubMed
    1. Howlader N, Noone AM, Krapcho M, et al., editors. SEER Cancer Statistics Review, 1975–2012. National Cancer Institute; Bethesda, MD: [Accessed October 5, 2015]. www.seer.cancer.gov/csr/1975_2012/. Published 2015.

Publication types